These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12709408

  • 1. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin.
    Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, Wallace JL.
    FASEB J; 2003 Jun; 17(9):1171-3. PubMed ID: 12709408
    [Abstract] [Full Text] [Related]

  • 2. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
    Fiorucci S, Distrutti E, Mencarelli A, Morelli A, Laufor SA, Cirino G, Wallace JL.
    Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
    Souza MH, de Lima OM, Zamuner SR, Fiorucci S, Wallace JL.
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G54-61. PubMed ID: 12637254
    [Abstract] [Full Text] [Related]

  • 5. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa.
    Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, Morelli A.
    Proc Natl Acad Sci U S A; 2003 Sep 16; 100(19):10937-41. PubMed ID: 12960371
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.
    Fiorucci S, de Lima OM, Mencarelli A, Palazzetti B, Distrutti E, McKnight W, Dicay M, Ma L, Romano M, Morelli A, Wallace JL.
    Gastroenterology; 2002 Nov 16; 123(5):1598-606. PubMed ID: 12404234
    [Abstract] [Full Text] [Related]

  • 7. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).
    Titos E, Chiang N, Serhan CN, Romano M, Gaya J, Pueyo G, Clària J.
    Am J Physiol; 1999 Nov 16; 277(5):C870-7. PubMed ID: 10564079
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S, Ogawa Y, Kanatsu K, Okayama M, Watanabe T, Arakawa T, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Nov 16; 303(2):503-9. PubMed ID: 12388629
    [Abstract] [Full Text] [Related]

  • 12. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
    Vidal C, Gómez-Hernández A, Sánchez-Galán E, González A, Ortega L, Gómez-Gerique JA, Tuñón J, Egido J.
    J Pharmacol Exp Ther; 2007 Jan 16; 320(1):108-16. PubMed ID: 17015640
    [Abstract] [Full Text] [Related]

  • 13. Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
    Alvaro-Gracia JM.
    Rheumatology (Oxford); 2004 Feb 16; 43 Suppl 1():i21-5. PubMed ID: 14752172
    [Abstract] [Full Text] [Related]

  • 14. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038
    [Abstract] [Full Text] [Related]

  • 15. SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
    Kim JH, Rhee HI, Jung IH, Ryu K, Jung K, Han CK, Kwak WJ, Cho YB, Joo HJ.
    Life Sci; 2005 Jul 29; 77(11):1181-93. PubMed ID: 15935401
    [Abstract] [Full Text] [Related]

  • 16. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T, Konturek PC, Pajdo R, Ptak-Belowska A, Kwiecien S, Pawlik M, Drozdowicz D, Sliwowski Z, Brzozowski B, Konturek SJ, Pawlik WW.
    J Physiol Pharmacol; 2008 Aug 29; 59 Suppl 2():89-102. PubMed ID: 18812631
    [Abstract] [Full Text] [Related]

  • 17. A magic bullet for mucosal protection...and aspirin is the trigger!
    Wallace JL, Fiorucci S.
    Trends Pharmacol Sci; 2003 Jul 29; 24(7):323-6. PubMed ID: 12871661
    [No Abstract] [Full Text] [Related]

  • 18. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
    Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN.
    J Pharmacol Exp Ther; 1998 Nov 29; 287(2):779-90. PubMed ID: 9808710
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K, Suzuki K, Yamamoto H, Araki H, Mizoguchi H, Ukawa H.
    J Physiol Pharmacol; 1998 Dec 29; 49(4):501-13. PubMed ID: 10069692
    [Abstract] [Full Text] [Related]

  • 20. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B, Ehrlich K, Maricic N, Lambrecht N, Respondek M, Peskar BM.
    Br J Pharmacol; 1998 Mar 29; 123(5):927-35. PubMed ID: 9535022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.